,
, REMEMBER WAY BACK WHEN BEFORE THE PANDEMIC BEGAN WE SAT DOWN WITH THE NEW
PRESIDENT FRED HUTCHINSON
CANCER RESEARCH CENTER.
>> THAT WAS BACK IN JANUARY.
AND SINCE THEN HUCH HAS BEEN
VERY BUSY LEADING RESEARCH
AGAINST COVA.
DR. LYNCH JOINS US NOW FOR AN
UPDATE.
TOM, HAVE YOU HAD A DAY OFF
SINCE ALL THIS STARTED?
>> WELL, ACTUALLY I DON'T THINK
SO.
>> IT'S BEEN AN INCREDIBLY
INTENSE FOR EVERYBODY AT THE
HUTCH WORKING ON CORBITT AND
CONTINUE TO WORK REALLY HARD ON
CANCER.
YOU ARE DOING AMAZING THINGS
THERE.
>> LET'S GET STARTED WITH THE
LATEST NEWS YOU JUST OPEN THE
KOFOD 19 CLINICAL RESEARCH
CENTER AND ANOTHER FACILITY.
WHAT ARE SCIENTISTS DOING
THERE?
>> SO TWO THINGS.
SO AMY, WHAT ARE THE MOST
IMPORTANT THINGS ABOUT
KOBAN RESEARCH IS EVERYTHING WE
KNOW ABOUT DRUGS LIKE RED
DESERT BEER ANDEXANET ZONE AND
THE MONARCHAL ANTIBODIES ARE IN
PATIENTS WHO ARE HOSPITALIZED
WHO HAVE A LOT OF DISEASE
THAT'S VERY ADVANCED IN NATURE
.
WHAT WE REALLY WANT TO FIND OUT
IS HOW DID THESE DRUGS WORK FOR
PEOPLE WITH EARLY DISEASE?
WHEN YOU HAVE A CHANCE TO
POSSIBLY PREVENT THEM FROM
BECOMING HOSPITALIZED?
WELL, TO DO THAT YOU NEED A
DYNAMIC PHANTASM OUTPATIENT
CLINICAL RESEARCH CENTER AND
THAT'S WHAT THE COLD CLINICAL
RESEARCH CENTER IS.
IT'S A SPECIFIC BUILDING WE LAB
AT THE HUTCH JUST FOR PATIENTS
WHO ARE PARTICIPATING EITHER IN
VACCINE TRIALS OR OUR SUBJECTS
ARE VOLUNTEERS FOR TREATMENT
TRIALS.
SO IT'S A CLINICAL RESEARCH
CENTER THAT WE ARE INCREDIBLY
PROUD OF THAT IS SECOND HOME.
YEAH, IT'S REALLY REMARKABLE
AND IT GIVES IT GIVES ACCESS TO
EARLY STUDIES FOR A WHOLE
PATIENT POPULATION THAT YOU
DIDN'T HAVE BEFORE.
>> YOU'RE TALKING ABOUT LIKE
REM DVR OR ARE DRUGS THAT HAVE
BEEN ALREADY ON THE MARKET.
YOU NEED ALL THAT DATA TO LOOK
AND SEE.
CORRECT.
IF THIS IS GOING TO BE A VALID
TREATMENT YOU ABSOLUTELY DO.
>> AND FOR EXAMPLE,
PARTICULARLY IN CANCER AS WELL
WHEN YOU'RE LOOKING WHEN YOU'RE
DOING STUDIES EARLY IN CANCER,
YOU GENERATE LOTS OF DATA.
IT'S VERY DIFFICULT TO KNOW
WHAT'S NOISE AND WHAT IS GIVING
YOU A SIGNAL THAT CAN POINT YOU
TO A NEW TREATMENT THAT COULD
MAKE A DIFFERENCE FOR PATIENTS.
AND THAT'S WHY THAT
INTERSECTION BETWEEN HAVING
BIOLOGISTS WORK WITH DATA
SCIENTISTS IS SO CRITICAL
BECAUSE DATA SCIENTISTS CAN'T
DO IT ON THEIR OWN.
>> BIOLOGISTS CAN'T DO IT ON
THEIR OWN.
>> YOU MENTIONED CANCER AND
WE'VE HEARD THAT THE PANDEMIC
HAS IMPACT THAT CANCER
DIAGNOSES AS A LEADING CANCER
CENTER.
WHAT WHAT CAN BE DONE TO
ADDRESS THIS ISSUE?
>> SO I THINK I THINK EMILY,
ONE OF THE THINGS I'M CONCERNED
ABOUT IS THAT WITH THE PANDEMIC
PEOPLE ARE PUTTING OFF THEIR
SCREENINGS.
THEY'RE PUTTING OFF THEIR
MAMMOGRAMS, THEY'RE PUTTING OFF
THEY'RE CALLING ON ESCAPEE'S
BECAUSE LISTEN, THESE ARE
THINGS THAT PEOPLE THINK, WELL,
YOU KNOW, I DON'T HAVE TO DO IT
THIS YEAR.
>> WELL, IF YOU FORGET ABOUT
DOING IT, YOU MISS THE CHANCE
TO CATCH CANCERS EARLY AND
THOSE ARE THE CANCERS WE CAN
CURE.
>> AND THERE'S BEEN A STUDY
THAT'S BEEN DONE BY THE
NATIONAL CANCER INSTITUTE THAT
SUGGESTS THAT THERE MAY BE AN
ADDITIONAL 10000 DEATHS FROM
CANCER OVER THE NEXT DECADE
FROM PEOPLE WHO MISSED
SCREENING THIS YEAR.
>> REALLY IMPORTANT TO KEEP UP
YOUR CANCER SCREENINGS.
YOU CAN'T LET THAT LAPSE.
>> I'M 41 WITHOUT A MAMMOGRAM
AND I'M GOING TO GET ONE IN A
FEW WEEKS.
SO THAT IS PLASTIC.
>> FANTASTIC.
IT'S VERY IMPORTANT.
IT IS SO IMPORTANT.
SO I HAVE A QUICK QUESTION
FINAL QUESTION FOR YOU.
WHAT HAVE YOU LEARNED AS A
LEADER DURING THIS PANDEMIC
THAT YOU'RE GOING TO CARRY WITH
YOU AS YOU MOVE FORWARD?
AS WE ALL MOVE FORWARD?
>> SO I'D SAY A COUPLE THINGS.
>> I MEAN I THINK FIRST WE
CRAVE CONNECTION WITH EACH
OTHER AND LOOK.
WE TRY TO DO IT ON ZOOME CALLS
.
>> WE TRY TO DO IT IN VIRTUAL
WAYS.
BUT BUT PEOPLE REALLY NEED TO
BE TOGETHER SOCIALLY WORKWISE.
>> AND I THINK THAT WE'RE GOING
TO FIND WAYS TO DO THAT WHEN
THE PANDEMICS OVER SECOND.
I THINK THERE'S SOME PEOPLE WHO
CAN WORK REMOTELY IN A WAY THAT
CAN STILL BE INCREDIBLE WAY TO
CONTRIBUTE TO THE MISSION
OF THE HUCH OR ANY OTHER
BUSINESS OR MISSION.
>> SO I THINK WE'VE LEARNED A
LOT ABOUT THE WAY WE WORK.
AND THEN FINALLY I'D SAY ABOUT
SEATTLE I LEARNED ABOUT THE
REMARKABLE RESILIENCE OF THE
PEOPLE WHO ARE HERE.
>> THIS IS TRULY A REMARKABLE
REGION.
THE PEOPLE ARE EXTREMELY
MOTIVATED AND AND VERY MISSION
DRIVEN TO HELPING US LOOK AT
CODE AND END TO DEFEAT CANCER.
>> THAT MAKES MY HEART HAPPY TO
HEAR IT.
>> IT IS SO TRUE WE ARE STRONG
FOMO CARE REALLY QUICKLY.
WHERE CAN PEOPLE GO TO GET MORE
INFORMATION?
FIND OUT HOW WE CAN HELP THE
HUCH SO WE'VE GOT THE FRED
HUTCH WEB SITE.
>> AND WE'LL BE HAPPY TO GIVE
YOU THAT YOU OR ELSE SO THAT
YOU CAN SHOW THAT IT'S A
WONDERFUL OPPORTUNITY FOR
PEOPLE WHO MIGHT BE INTERESTED
IN PARTICIPATING IN SOME
OF THESE TRIALS AS A AS A
VOLUNTEER OR AS A SUBJECT IN
SOME OF THE CLINICAL TRIALS.
>> WE'D BE DELIGHTED TO DO THAT
AND ANYTHING ELSE ABOUT CANCER
EARLY DETECTION TREATMENT AT
THE HUTCH?
>> WE'LL GET TO THAT WEB SITE
INFORMATION.
>> THANK YOU SO MUCH, DR.
LYNCH.
IT IS A PLEASURE TO TALK WITH
YOU AGAIN AND